Table 3.
Parameter | Sarcopenics (n = 55) | Nonsarcopenics (n = 60) | P value |
---|---|---|---|
90-day Mortality | 5 (9.09) | 4 (6.66) | 0.63 |
Bleeding requiring BT | 2 (3.6) | 0 (0.0) | 0.22 |
HAT | 2 (3.6) | 0 (0.0) | 0.14 |
PVT | 1 (1.9) | 1 (1.8) | 1.0 |
Exploratory laparotomy | 7 (12.7) | 2 (3.3) | 0.064 |
|
2 (28.6) | 1 (50.0) | |
|
1 (14.4) | 0 (0.0) | |
|
2 (28.6) | 0 (0.0) | |
|
2 (28.6) | 1(50.0) | |
Sepsis | 49 (89) | 33 (55) | 0.001* |
|
9 (16.3) | 5 (8.3) | |
|
6 (10.9) | 4 (6.7) | |
|
22 (40) | 16 (26.7) | |
|
12 (21.8) | 8 (13.3) | |
Neurologic complications | 16 (29.6) | 5 (8.8) | 0.040* |
Clavien-Dindo score ≥3 | 24 (43.6) | 15 (25.4) | 0.041* |
Data presented as number (percentage).
*Significant at P < 0.05.
BT, Blood transfusion, HAT, Hepatic artery thrombosis; PVT, Portal vein thrombosis.